CPI and BRIC sign Letter of Intent to strengthen UK-India biomanufacturing collaboration

CPI and India's Biotechnology Research and Innovation Council (BRIC) have signed a Letter of Intent (LoI) to establish a strategic UK-India Biomanufacturing Partnership.

The partnership will strengthen collaboration between two nations with ambitious plans to accelerate biotechnology innovation, scale-up and commercialisation. It's the latest step in a campaign to deepen UK-India collaboration in critical and emerging technologies, supporting ambitions set out under the UK-India Technology Security Initiative (TSI). The development follows a CPI-led UK delegation of 20 high-potential biomanufacturing and pharmaceutical SMEs to India in early 2026 which positioned the UK as a partner of choice for global collaboration.

The agreement establishes the foundation for a long-term strategic relationship between CPI and BRIC, supported through joint governance arrangements and the exploration of co-invested programmes and projects in priority areas of shared interest.   

The collaboration will focus on identifying and accelerating high-potential innovations across biotherapeutics including vaccines and industrial biotechnology. It will also explore opportunities to strengthen scale-up pathways, support commercialisation, build skills and talent, facilitate knowledge exchange, and encourage collaboration between research organisations, industry, start-ups and SMEs in both countries.